123 related articles for article (PubMed ID: 8222519)
1. Dimethyl sulfoxide for treating anthracycline extravasation.
Rospond RM; Engel LM
Clin Pharm; 1993 Aug; 12(8):560-1. PubMed ID: 8222519
[No Abstract] [Full Text] [Related]
2. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone.
Langer SW; Thougaard AV; Sehested M; Jensen PB
Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176
[TBL] [Abstract][Full Text] [Related]
3. Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation.
Llinares ME; Bermúdez M; Fuster JL; Diaz MS; Gonzalez CM
Pediatr Hematol Oncol; 2005; 22(1):49-52. PubMed ID: 15770831
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl sulfoxide therapy in the treatment of vesicant extravasation: two case presentations.
St Germain B; Houlihan N; D'Amato S
J Intraven Nurs; 1994; 17(5):261-6. PubMed ID: 7965372
[TBL] [Abstract][Full Text] [Related]
5. Scrotal ulceration: a complication of hyperthermic intraperitoneal chemotherapy and subsequent treatment with dimethyl sulfoxide.
Bartlett K; Derrington S; Jariwala N; Mai C; Koo B
Cutis; 2019 Jul; 104(1):E1-E3. PubMed ID: 31487345
[No Abstract] [Full Text] [Related]
6. Re: Totect: a new agent for treating anthracycline extravasation.
Ward MS
Clin J Oncol Nurs; 2007 Oct; 11(5):613; author reply 613. PubMed ID: 17962168
[No Abstract] [Full Text] [Related]
7. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation.
Olver IN; Aisner J; Hament A; Buchanan L; Bishop JF; Kaplan RS
J Clin Oncol; 1988 Nov; 6(11):1732-5. PubMed ID: 3183703
[TBL] [Abstract][Full Text] [Related]
8. Dexrazoxane: new indication. Anthracycline extravasation: continue using dimethyl sulfoxide.
Prescrire Int; 2009 Feb; 18(99):6-8. PubMed ID: 19382398
[TBL] [Abstract][Full Text] [Related]
9. Accidental anthracycline extravasation.
Held-Warmkessel J
Nursing; 2007 Dec; 37(12 Pt.1):72. PubMed ID: 18090648
[No Abstract] [Full Text] [Related]
10. Totect: a new agent for treating anthracycline extravasation.
Schulmeister L
Clin J Oncol Nurs; 2007 Jun; 11(3):387-95. PubMed ID: 17623623
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline extravasation: a comprehensive review of experimental and clinical treatments.
Langer SW; Sehested M; Jensen PB
Tumori; 2009; 95(3):273-82. PubMed ID: 19688963
[TBL] [Abstract][Full Text] [Related]
12. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.
Lawrence HJ; Walsh D; Zapotowski KA; Denham A; Goodnight SH; Gandara DR
Cancer Chemother Pharmacol; 1989; 23(5):316-8. PubMed ID: 2706738
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline extravasations: prevention and management.
Roe H
Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S16, S18-22. PubMed ID: 22067533
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl sulfoxide and extravasation of anthracycline agents.
Lawrence HJ; Goodnight SH
Ann Intern Med; 1983 Jun; 98(6):1025. PubMed ID: 6574721
[No Abstract] [Full Text] [Related]
15. Evaluation of dimethyl sulfoxide and local cooling as antidotes for doxorubicin extravasation in a pig model.
Harwood KV; Bachur N
Oncol Nurs Forum; 1987; 14(1):39-44. PubMed ID: 3643588
[No Abstract] [Full Text] [Related]
16. A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane.
Bos AM; van der Graaf WT; Willemse PH
Acta Oncol; 2001; 40(4):541-2. PubMed ID: 11504316
[No Abstract] [Full Text] [Related]
17. DMSO and extravasation of mitomycin.
Herrera D; Burnham N
Oncol Nurs Forum; 1989; 16(2):155. PubMed ID: 2928263
[No Abstract] [Full Text] [Related]
18. Extravasation: a dreaded complication of chemotherapy.
Schrijvers DL
Ann Oncol; 2003; 14 Suppl 3():iii26-30. PubMed ID: 12821535
[No Abstract] [Full Text] [Related]
19. Management of doxorubicin extravasation.
Harwood KV; Vito B; Brady P; Much J; Krzysko-Depew A; Wagler K; Strauman J
Oncol Nurs Forum; 1989; 16(1):10-1. PubMed ID: 2911516
[No Abstract] [Full Text] [Related]
20. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
